World's largest Takayasu's registry launches to unlock disease secrets

NCT ID NCT07558382

Recruiting now Knowledge-focused Sponsor: Marmara University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This global registry is collecting information from 1,000 people with Takayasu's arteritis, a rare disease that inflames and narrows large arteries. Researchers will analyze patients' symptoms, lab results, imaging, and treatments to see how the disease behaves and is managed around the world. The study does not test any new drug or procedure—it simply observes and records what happens in routine care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could help doctors worldwide better understand and manage Takayasu's arteritis, leading to improved diagnosis and treatment guidelines.
What could go wrong: This is an observational study, not a treatment trial. It collects existing data and does not test any new therapy, so it cannot directly lead to a cure or new drug.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TAKAYASU ARTERITIS (TAK) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Takayasu arteritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TAKAYASU ARTERITIS (TAK) TAKAYASU'S ARTERITIS

Contacts and locations

Locations

Marmara University School of Medicine
RECRUITING

Istanbul, Istanbul, 34899, Turkey (Türkiye)
Marmara University School of Medicine
RECRUITING

Istanbul, Istanbul, 34899, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.